Lower levels of baseline FT are associated with a greater risk of incident or worsening mobility limitation in community-dwelling older men. Whether this risk can be reduced with testosterone therapy needs to be determined by randomized trials.
No takes yet. Share an insight, caveat, or question.
Krasnoff et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: